FR | EN

Article

Antibiotic resistance is accelerating. But it existed long before us.

Antimicrobial resistance refers to bacteria's ability to survive treatments that once killed them — an evolutionary mechanism as old as microbial life itself, now massively amplified by human antibiotic use.

What science confirms

Resistance genes predate the medical era — found in environmental samples thousands of years old. What human use triggered is a selection pressure that accelerates their spread at an unprecedented rate.

Horizontal gene transfer: bacteria exchange resistance genes across species via plasmids, without reproduction — a lateral adaptation impossible in higher organisms (Kiplimo et al., 2025; Wu et al., 2025).

Biofilms: these structured bacterial communities survive normally lethal concentrations by slowing their own metabolism (Azeem et al., 2025; Liu & Webber, 2024).

Efflux pumps: certain bacteria actively expel antibiotic molecules before they reach their intracellular target (Novelli & Bolla, 2024).

The global burden is documented: 4.95 million deaths associated with AMR in 2019, with projections reaching 10 million per year by 2050 (Naghavi et al., 2024).

What research qualifies

Developing new antibiotics will not be enough. The timeline from discovery to approval exceeds 10 years — and bacterial evolution has historically circumvented every new drug class. The most promising approaches (nanotechnology, microbiome modulation, AI-assisted antibiotic stewardship) still lack large-scale clinical validation (Parvin et al., 2025; Dongre et al., 2025; Pennisi et al., 2025).

Open questions for research

Sources

📄 Associated Scinuance Report

Access the full report on antibiotic resistance: complete scientific sources, bibliography analysis and synthesis of uncertainties.

View the report →

← Back to blog